Global AI-based Diabetic Eye Disease Screening System Supply, Demand and Key Producers, 2026-2032
The global AI-based Diabetic Eye Disease Screening System market size is expected to reach $ 616 million by 2032, rising at a market growth of 6.6% CAGR during the forecast period (2026-2032).
AI-based diabetic eye disease screening systems are intelligent diagnostic support tools developed using deep learning, computer vision, and medical image analysis technologies. These systems capture retinal images?using fundus cameras, ultra-widefield fundus cameras, or portable retinal cameras?and employ AI algorithms, such as convolutional neural networks, to automatically detect diabetic retinopathy, diabetic macular edema (DME), and other fundus abnormalities. Based on international clinical grading standards, they generate outputs regarding the need for referral, the severity of lesions, and preliminary diagnostic findings. Typically integrating features such as image quality assessment, automated lesion detection, disease grading, risk prediction, electronic medical record (EMR) interfaces, and cloud-based data management, these systems can be deployed in hospitals, primary care facilities, health check-up centers, diabetes clinics, and mobile medical settings. This enables large-scale, efficient, and standardized screening for diabetic eye disease, thereby increasing early detection rates and alleviating the shortage of ophthalmologists.
As the global diabetic population grows and diabetic retinopathy emerges as a leading cause of adult blindness?coupled with strengthened government policies on screening for diabetes complications?the market for AI-based diabetic eye disease screening systems is entering a phase of rapid commercialization. In recent years, countries and regions including the United States, China, Europe, Japan, and India have approved AI-assisted fundus screening products for clinical use, marking the transition of AI from a research concept to a standardized medical tool. Looking ahead, driven by improvements in AI algorithm accuracy, the widespread adoption of non-mydriatic fundus cameras, the digitalization of primary care, and the refinement of health insurance reimbursement systems, AI screening systems will expand from tertiary hospitals to community clinics, health check-up centers, pharmacies, mobile screening units, and home health management settings. Furthermore, by integrating cloud computing, telemedicine, large-model-assisted diagnostics, multi-disease screening, and continuous health management services, these systems will form a comprehensive business model?'Device + AI Software + Cloud Platform + Chronic Disease Management'?with the global market expected to maintain high growth rates in the coming years.
This report studies the global AI-based Diabetic Eye Disease Screening System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-based Diabetic Eye Disease Screening System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-based Diabetic Eye Disease Screening System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-based Diabetic Eye Disease Screening System total market, 2021-2032, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI-based Diabetic Eye Disease Screening System total market, key domestic companies, and share, (USD Million)
Global AI-based Diabetic Eye Disease Screening System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI-based Diabetic Eye Disease Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eyenuk, AEYE Health, Optomed, Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI-based Diabetic Eye Disease Screening System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI-based Diabetic Eye Disease Screening System Market, By Region:
1. How big is the global AI-based Diabetic Eye Disease Screening System market?
2. What is the demand of the global AI-based Diabetic Eye Disease Screening System market?
3. What is the year over year growth of the global AI-based Diabetic Eye Disease Screening System market?
4. What is the total value of the global AI-based Diabetic Eye Disease Screening System market?
5. Who are the Major Players in the global AI-based Diabetic Eye Disease Screening System market?
6. What are the growth factors driving the market demand?
AI-based diabetic eye disease screening systems are intelligent diagnostic support tools developed using deep learning, computer vision, and medical image analysis technologies. These systems capture retinal images?using fundus cameras, ultra-widefield fundus cameras, or portable retinal cameras?and employ AI algorithms, such as convolutional neural networks, to automatically detect diabetic retinopathy, diabetic macular edema (DME), and other fundus abnormalities. Based on international clinical grading standards, they generate outputs regarding the need for referral, the severity of lesions, and preliminary diagnostic findings. Typically integrating features such as image quality assessment, automated lesion detection, disease grading, risk prediction, electronic medical record (EMR) interfaces, and cloud-based data management, these systems can be deployed in hospitals, primary care facilities, health check-up centers, diabetes clinics, and mobile medical settings. This enables large-scale, efficient, and standardized screening for diabetic eye disease, thereby increasing early detection rates and alleviating the shortage of ophthalmologists.
As the global diabetic population grows and diabetic retinopathy emerges as a leading cause of adult blindness?coupled with strengthened government policies on screening for diabetes complications?the market for AI-based diabetic eye disease screening systems is entering a phase of rapid commercialization. In recent years, countries and regions including the United States, China, Europe, Japan, and India have approved AI-assisted fundus screening products for clinical use, marking the transition of AI from a research concept to a standardized medical tool. Looking ahead, driven by improvements in AI algorithm accuracy, the widespread adoption of non-mydriatic fundus cameras, the digitalization of primary care, and the refinement of health insurance reimbursement systems, AI screening systems will expand from tertiary hospitals to community clinics, health check-up centers, pharmacies, mobile screening units, and home health management settings. Furthermore, by integrating cloud computing, telemedicine, large-model-assisted diagnostics, multi-disease screening, and continuous health management services, these systems will form a comprehensive business model?'Device + AI Software + Cloud Platform + Chronic Disease Management'?with the global market expected to maintain high growth rates in the coming years.
This report studies the global AI-based Diabetic Eye Disease Screening System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-based Diabetic Eye Disease Screening System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-based Diabetic Eye Disease Screening System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-based Diabetic Eye Disease Screening System total market, 2021-2032, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI-based Diabetic Eye Disease Screening System total market, key domestic companies, and share, (USD Million)
Global AI-based Diabetic Eye Disease Screening System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI-based Diabetic Eye Disease Screening System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI-based Diabetic Eye Disease Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eyenuk, AEYE Health, Optomed, Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI-based Diabetic Eye Disease Screening System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI-based Diabetic Eye Disease Screening System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- On-premise
- Cloud-based
- Hybrid Mode
- Software Licensing
- SaaS Subscription
- Per-Screening Fee
- Integrated AI + Hardware Sales
- Others
- General Hospitals
- Ophthalmology Hospitals
- Diabetes Specialty Hospitals
- Eyenuk
- AEYE Health
- Optomed
- Remidio
- Retmarker
- VoxelCloud
- Airdoc
- Zhiyuan Huitu
- IDx, LLC
- Zhenhealth
1. How big is the global AI-based Diabetic Eye Disease Screening System market?
2. What is the demand of the global AI-based Diabetic Eye Disease Screening System market?
3. What is the year over year growth of the global AI-based Diabetic Eye Disease Screening System market?
4. What is the total value of the global AI-based Diabetic Eye Disease Screening System market?
5. Who are the Major Players in the global AI-based Diabetic Eye Disease Screening System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI-based Diabetic Eye Disease Screening System Introduction
1.2 World AI-based Diabetic Eye Disease Screening System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI-based Diabetic Eye Disease Screening System Total Market by Region (by Headquarter Location)
1.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.3 China Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.4 Europe Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.5 Japan Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.6 South Korea Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.7 ASEAN Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.8 India Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-based Diabetic Eye Disease Screening System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.2 World AI-based Diabetic Eye Disease Screening System Consumption Value by Region
2.2.1 World AI-based Diabetic Eye Disease Screening System Consumption Value by Region (2021-2026)
2.2.2 World AI-based Diabetic Eye Disease Screening System Consumption Value Forecast by Region (2027-2032)
2.3 United States AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.4 China AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.5 Europe AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.6 Japan AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.7 South Korea AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.8 ASEAN AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.9 India AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
3 WORLD AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-based Diabetic Eye Disease Screening System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-based Diabetic Eye Disease Screening System in 2025
3.2.3 Global Concentration Ratios (CR8) for AI-based Diabetic Eye Disease Screening System in 2025
3.3 AI-based Diabetic Eye Disease Screening System Company Evaluation Quadrant
3.4 AI-based Diabetic Eye Disease Screening System Market: Overall Company Footprint Analysis
3.4.1 AI-based Diabetic Eye Disease Screening System Market: Region Footprint
3.4.2 AI-based Diabetic Eye Disease Screening System Market: Company Product Type Footprint
3.4.3 AI-based Diabetic Eye Disease Screening System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI-based Diabetic Eye Disease Screening System Consumption Value Comparison
4.2.1 United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI-based Diabetic Eye Disease Screening System Companies and Market Share, 2021-2026
4.3.1 United States Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026)
4.4 China Based Companies AI-based Diabetic Eye Disease Screening System Revenue and Market Share, 2021-2026
4.4.1 China Based AI-based Diabetic Eye Disease Screening System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026)
4.5 Rest of World Based AI-based Diabetic Eye Disease Screening System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-premise
5.2.2 Cloud-based
5.2.3 Hybrid Mode
5.3 Market Segment by Type
5.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
5.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
5.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BUSINESS MODEL
6.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Business Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Business Model
6.2.1 Software Licensing
6.2.2 SaaS Subscription
6.2.3 Per-Screening Fee
6.2.4 Integrated AI + Hardware Sales
6.2.5 Others
6.3 Market Segment by Business Model
6.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2021-2026)
6.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2027-2032)
6.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 General Hospitals
7.2.2 Ophthalmology Hospitals
7.2.3 Diabetes Specialty Hospitals
7.3 Market Segment by Application
7.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
7.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
7.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Eyenuk
8.1.1 Eyenuk Details
8.1.2 Eyenuk Major Business
8.1.3 Eyenuk AI-based Diabetic Eye Disease Screening System Product and Services
8.1.4 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Eyenuk Recent Developments/Updates
8.1.6 Eyenuk Competitive Strengths & Weaknesses
8.2 AEYE Health
8.2.1 AEYE Health Details
8.2.2 AEYE Health Major Business
8.2.3 AEYE Health AI-based Diabetic Eye Disease Screening System Product and Services
8.2.4 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 AEYE Health Recent Developments/Updates
8.2.6 AEYE Health Competitive Strengths & Weaknesses
8.3 Optomed
8.3.1 Optomed Details
8.3.2 Optomed Major Business
8.3.3 Optomed AI-based Diabetic Eye Disease Screening System Product and Services
8.3.4 Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Optomed Recent Developments/Updates
8.3.6 Optomed Competitive Strengths & Weaknesses
8.4 Remidio
8.4.1 Remidio Details
8.4.2 Remidio Major Business
8.4.3 Remidio AI-based Diabetic Eye Disease Screening System Product and Services
8.4.4 Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Remidio Recent Developments/Updates
8.4.6 Remidio Competitive Strengths & Weaknesses
8.5 Retmarker
8.5.1 Retmarker Details
8.5.2 Retmarker Major Business
8.5.3 Retmarker AI-based Diabetic Eye Disease Screening System Product and Services
8.5.4 Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Retmarker Recent Developments/Updates
8.5.6 Retmarker Competitive Strengths & Weaknesses
8.6 VoxelCloud
8.6.1 VoxelCloud Details
8.6.2 VoxelCloud Major Business
8.6.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Product and Services
8.6.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 VoxelCloud Recent Developments/Updates
8.6.6 VoxelCloud Competitive Strengths & Weaknesses
8.7 Airdoc
8.7.1 Airdoc Details
8.7.2 Airdoc Major Business
8.7.3 Airdoc AI-based Diabetic Eye Disease Screening System Product and Services
8.7.4 Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Airdoc Recent Developments/Updates
8.7.6 Airdoc Competitive Strengths & Weaknesses
8.8 Zhiyuan Huitu
8.8.1 Zhiyuan Huitu Details
8.8.2 Zhiyuan Huitu Major Business
8.8.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product and Services
8.8.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Zhiyuan Huitu Recent Developments/Updates
8.8.6 Zhiyuan Huitu Competitive Strengths & Weaknesses
8.9 IDx, LLC
8.9.1 IDx, LLC Details
8.9.2 IDx, LLC Major Business
8.9.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Product and Services
8.9.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 IDx, LLC Recent Developments/Updates
8.9.6 IDx, LLC Competitive Strengths & Weaknesses
8.10 Zhenhealth
8.10.1 Zhenhealth Details
8.10.2 Zhenhealth Major Business
8.10.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Product and Services
8.10.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Zhenhealth Recent Developments/Updates
8.10.6 Zhenhealth Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 AI-based Diabetic Eye Disease Screening System Industry Chain
9.2 AI-based Diabetic Eye Disease Screening System Upstream Analysis
9.3 AI-based Diabetic Eye Disease Screening System Midstream Analysis
9.4 AI-based Diabetic Eye Disease Screening System Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 AI-based Diabetic Eye Disease Screening System Introduction
1.2 World AI-based Diabetic Eye Disease Screening System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI-based Diabetic Eye Disease Screening System Total Market by Region (by Headquarter Location)
1.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.3 China Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.4 Europe Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.5 Japan Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.6 South Korea Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.7 ASEAN Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.3.8 India Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-based Diabetic Eye Disease Screening System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.2 World AI-based Diabetic Eye Disease Screening System Consumption Value by Region
2.2.1 World AI-based Diabetic Eye Disease Screening System Consumption Value by Region (2021-2026)
2.2.2 World AI-based Diabetic Eye Disease Screening System Consumption Value Forecast by Region (2027-2032)
2.3 United States AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.4 China AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.5 Europe AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.6 Japan AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.7 South Korea AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.8 ASEAN AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
2.9 India AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032)
3 WORLD AI-BASED DIABETIC EYE DISEASE SCREENING SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-based Diabetic Eye Disease Screening System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-based Diabetic Eye Disease Screening System in 2025
3.2.3 Global Concentration Ratios (CR8) for AI-based Diabetic Eye Disease Screening System in 2025
3.3 AI-based Diabetic Eye Disease Screening System Company Evaluation Quadrant
3.4 AI-based Diabetic Eye Disease Screening System Market: Overall Company Footprint Analysis
3.4.1 AI-based Diabetic Eye Disease Screening System Market: Region Footprint
3.4.2 AI-based Diabetic Eye Disease Screening System Market: Company Product Type Footprint
3.4.3 AI-based Diabetic Eye Disease Screening System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI-based Diabetic Eye Disease Screening System Consumption Value Comparison
4.2.1 United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI-based Diabetic Eye Disease Screening System Companies and Market Share, 2021-2026
4.3.1 United States Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026)
4.4 China Based Companies AI-based Diabetic Eye Disease Screening System Revenue and Market Share, 2021-2026
4.4.1 China Based AI-based Diabetic Eye Disease Screening System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026)
4.5 Rest of World Based AI-based Diabetic Eye Disease Screening System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 On-premise
5.2.2 Cloud-based
5.2.3 Hybrid Mode
5.3 Market Segment by Type
5.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
5.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
5.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BUSINESS MODEL
6.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Business Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Business Model
6.2.1 Software Licensing
6.2.2 SaaS Subscription
6.2.3 Per-Screening Fee
6.2.4 Integrated AI + Hardware Sales
6.2.5 Others
6.3 Market Segment by Business Model
6.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2021-2026)
6.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2027-2032)
6.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World AI-based Diabetic Eye Disease Screening System Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 General Hospitals
7.2.2 Ophthalmology Hospitals
7.2.3 Diabetes Specialty Hospitals
7.3 Market Segment by Application
7.3.1 World AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
7.3.2 World AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
7.3.3 World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Eyenuk
8.1.1 Eyenuk Details
8.1.2 Eyenuk Major Business
8.1.3 Eyenuk AI-based Diabetic Eye Disease Screening System Product and Services
8.1.4 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Eyenuk Recent Developments/Updates
8.1.6 Eyenuk Competitive Strengths & Weaknesses
8.2 AEYE Health
8.2.1 AEYE Health Details
8.2.2 AEYE Health Major Business
8.2.3 AEYE Health AI-based Diabetic Eye Disease Screening System Product and Services
8.2.4 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 AEYE Health Recent Developments/Updates
8.2.6 AEYE Health Competitive Strengths & Weaknesses
8.3 Optomed
8.3.1 Optomed Details
8.3.2 Optomed Major Business
8.3.3 Optomed AI-based Diabetic Eye Disease Screening System Product and Services
8.3.4 Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Optomed Recent Developments/Updates
8.3.6 Optomed Competitive Strengths & Weaknesses
8.4 Remidio
8.4.1 Remidio Details
8.4.2 Remidio Major Business
8.4.3 Remidio AI-based Diabetic Eye Disease Screening System Product and Services
8.4.4 Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Remidio Recent Developments/Updates
8.4.6 Remidio Competitive Strengths & Weaknesses
8.5 Retmarker
8.5.1 Retmarker Details
8.5.2 Retmarker Major Business
8.5.3 Retmarker AI-based Diabetic Eye Disease Screening System Product and Services
8.5.4 Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Retmarker Recent Developments/Updates
8.5.6 Retmarker Competitive Strengths & Weaknesses
8.6 VoxelCloud
8.6.1 VoxelCloud Details
8.6.2 VoxelCloud Major Business
8.6.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Product and Services
8.6.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 VoxelCloud Recent Developments/Updates
8.6.6 VoxelCloud Competitive Strengths & Weaknesses
8.7 Airdoc
8.7.1 Airdoc Details
8.7.2 Airdoc Major Business
8.7.3 Airdoc AI-based Diabetic Eye Disease Screening System Product and Services
8.7.4 Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Airdoc Recent Developments/Updates
8.7.6 Airdoc Competitive Strengths & Weaknesses
8.8 Zhiyuan Huitu
8.8.1 Zhiyuan Huitu Details
8.8.2 Zhiyuan Huitu Major Business
8.8.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product and Services
8.8.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Zhiyuan Huitu Recent Developments/Updates
8.8.6 Zhiyuan Huitu Competitive Strengths & Weaknesses
8.9 IDx, LLC
8.9.1 IDx, LLC Details
8.9.2 IDx, LLC Major Business
8.9.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Product and Services
8.9.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 IDx, LLC Recent Developments/Updates
8.9.6 IDx, LLC Competitive Strengths & Weaknesses
8.10 Zhenhealth
8.10.1 Zhenhealth Details
8.10.2 Zhenhealth Major Business
8.10.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Product and Services
8.10.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Zhenhealth Recent Developments/Updates
8.10.6 Zhenhealth Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 AI-based Diabetic Eye Disease Screening System Industry Chain
9.2 AI-based Diabetic Eye Disease Screening System Upstream Analysis
9.3 AI-based Diabetic Eye Disease Screening System Midstream Analysis
9.4 AI-based Diabetic Eye Disease Screening System Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-based Diabetic Eye Disease Screening System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI-based Diabetic Eye Disease Screening System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI-based Diabetic Eye Disease Screening System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI-based Diabetic Eye Disease Screening System Players in 2025
Table 12. World AI-based Diabetic Eye Disease Screening System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI-based Diabetic Eye Disease Screening System Company Evaluation Quadrant
Table 14. Head Office of Key AI-based Diabetic Eye Disease Screening System Players
Table 15. AI-based Diabetic Eye Disease Screening System Market: Company Product Type Footprint
Table 16. AI-based Diabetic Eye Disease Screening System Market: Company Product Application Footprint
Table 17. AI-based Diabetic Eye Disease Screening System Mergers & Acquisitions Activity
Table 18. United States VS China AI-based Diabetic Eye Disease Screening System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI-based Diabetic Eye Disease Screening System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 23. China Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 29. World AI-based Diabetic Eye Disease Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI-based Diabetic Eye Disease Screening System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model, (USD Million), 2021 & 2025 & 2032
Table 33. World AI-based Diabetic Eye Disease Screening System Market Size Value by Business Model (2021-2026) & (USD Million)
Table 34. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2027-2032) & (USD Million)
Table 35. World AI-based Diabetic Eye Disease Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & (USD Million)
Table 37. World AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032) & (USD Million)
Table 38. Eyenuk Basic Information, Manufacturing Base and Competitors
Table 39. Eyenuk Major Business
Table 40. Eyenuk AI-based Diabetic Eye Disease Screening System Product and Services
Table 41. Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Eyenuk Recent Developments/Updates
Table 43. Eyenuk Competitive Strengths & Weaknesses
Table 44. AEYE Health Basic Information, Manufacturing Base and Competitors
Table 45. AEYE Health Major Business
Table 46. AEYE Health AI-based Diabetic Eye Disease Screening System Product and Services
Table 47. AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. AEYE Health Recent Developments/Updates
Table 49. AEYE Health Competitive Strengths & Weaknesses
Table 50. Optomed Basic Information, Manufacturing Base and Competitors
Table 51. Optomed Major Business
Table 52. Optomed AI-based Diabetic Eye Disease Screening System Product and Services
Table 53. Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Optomed Recent Developments/Updates
Table 55. Optomed Competitive Strengths & Weaknesses
Table 56. Remidio Basic Information, Manufacturing Base and Competitors
Table 57. Remidio Major Business
Table 58. Remidio AI-based Diabetic Eye Disease Screening System Product and Services
Table 59. Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Remidio Recent Developments/Updates
Table 61. Remidio Competitive Strengths & Weaknesses
Table 62. Retmarker Basic Information, Manufacturing Base and Competitors
Table 63. Retmarker Major Business
Table 64. Retmarker AI-based Diabetic Eye Disease Screening System Product and Services
Table 65. Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Retmarker Recent Developments/Updates
Table 67. Retmarker Competitive Strengths & Weaknesses
Table 68. VoxelCloud Basic Information, Manufacturing Base and Competitors
Table 69. VoxelCloud Major Business
Table 70. VoxelCloud AI-based Diabetic Eye Disease Screening System Product and Services
Table 71. VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. VoxelCloud Recent Developments/Updates
Table 73. VoxelCloud Competitive Strengths & Weaknesses
Table 74. Airdoc Basic Information, Manufacturing Base and Competitors
Table 75. Airdoc Major Business
Table 76. Airdoc AI-based Diabetic Eye Disease Screening System Product and Services
Table 77. Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Airdoc Recent Developments/Updates
Table 79. Airdoc Competitive Strengths & Weaknesses
Table 80. Zhiyuan Huitu Basic Information, Manufacturing Base and Competitors
Table 81. Zhiyuan Huitu Major Business
Table 82. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product and Services
Table 83. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Zhiyuan Huitu Recent Developments/Updates
Table 85. Zhiyuan Huitu Competitive Strengths & Weaknesses
Table 86. IDx, LLC Basic Information, Manufacturing Base and Competitors
Table 87. IDx, LLC Major Business
Table 88. IDx, LLC AI-based Diabetic Eye Disease Screening System Product and Services
Table 89. IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. IDx, LLC Recent Developments/Updates
Table 91. IDx, LLC Competitive Strengths & Weaknesses
Table 92. Zhenhealth Basic Information, Manufacturing Base and Competitors
Table 93. Zhenhealth Major Business
Table 94. Zhenhealth AI-based Diabetic Eye Disease Screening System Product and Services
Table 95. Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Zhenhealth Recent Developments/Updates
Table 97. Zhenhealth Competitive Strengths & Weaknesses
Table 98. Global Key Players of AI-based Diabetic Eye Disease Screening System Upstream (Raw Materials)
Table 99. Global AI-based Diabetic Eye Disease Screening System Typical Customers
Table 1. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-based Diabetic Eye Disease Screening System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI-based Diabetic Eye Disease Screening System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI-based Diabetic Eye Disease Screening System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI-based Diabetic Eye Disease Screening System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI-based Diabetic Eye Disease Screening System Players in 2025
Table 12. World AI-based Diabetic Eye Disease Screening System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI-based Diabetic Eye Disease Screening System Company Evaluation Quadrant
Table 14. Head Office of Key AI-based Diabetic Eye Disease Screening System Players
Table 15. AI-based Diabetic Eye Disease Screening System Market: Company Product Type Footprint
Table 16. AI-based Diabetic Eye Disease Screening System Market: Company Product Application Footprint
Table 17. AI-based Diabetic Eye Disease Screening System Mergers & Acquisitions Activity
Table 18. United States VS China AI-based Diabetic Eye Disease Screening System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI-based Diabetic Eye Disease Screening System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 23. China Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-based Diabetic Eye Disease Screening System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI-based Diabetic Eye Disease Screening System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI-based Diabetic Eye Disease Screening System Revenue Market Share (2021-2026)
Table 29. World AI-based Diabetic Eye Disease Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI-based Diabetic Eye Disease Screening System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model, (USD Million), 2021 & 2025 & 2032
Table 33. World AI-based Diabetic Eye Disease Screening System Market Size Value by Business Model (2021-2026) & (USD Million)
Table 34. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model (2027-2032) & (USD Million)
Table 35. World AI-based Diabetic Eye Disease Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026) & (USD Million)
Table 37. World AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032) & (USD Million)
Table 38. Eyenuk Basic Information, Manufacturing Base and Competitors
Table 39. Eyenuk Major Business
Table 40. Eyenuk AI-based Diabetic Eye Disease Screening System Product and Services
Table 41. Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Eyenuk Recent Developments/Updates
Table 43. Eyenuk Competitive Strengths & Weaknesses
Table 44. AEYE Health Basic Information, Manufacturing Base and Competitors
Table 45. AEYE Health Major Business
Table 46. AEYE Health AI-based Diabetic Eye Disease Screening System Product and Services
Table 47. AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. AEYE Health Recent Developments/Updates
Table 49. AEYE Health Competitive Strengths & Weaknesses
Table 50. Optomed Basic Information, Manufacturing Base and Competitors
Table 51. Optomed Major Business
Table 52. Optomed AI-based Diabetic Eye Disease Screening System Product and Services
Table 53. Optomed AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Optomed Recent Developments/Updates
Table 55. Optomed Competitive Strengths & Weaknesses
Table 56. Remidio Basic Information, Manufacturing Base and Competitors
Table 57. Remidio Major Business
Table 58. Remidio AI-based Diabetic Eye Disease Screening System Product and Services
Table 59. Remidio AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Remidio Recent Developments/Updates
Table 61. Remidio Competitive Strengths & Weaknesses
Table 62. Retmarker Basic Information, Manufacturing Base and Competitors
Table 63. Retmarker Major Business
Table 64. Retmarker AI-based Diabetic Eye Disease Screening System Product and Services
Table 65. Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Retmarker Recent Developments/Updates
Table 67. Retmarker Competitive Strengths & Weaknesses
Table 68. VoxelCloud Basic Information, Manufacturing Base and Competitors
Table 69. VoxelCloud Major Business
Table 70. VoxelCloud AI-based Diabetic Eye Disease Screening System Product and Services
Table 71. VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. VoxelCloud Recent Developments/Updates
Table 73. VoxelCloud Competitive Strengths & Weaknesses
Table 74. Airdoc Basic Information, Manufacturing Base and Competitors
Table 75. Airdoc Major Business
Table 76. Airdoc AI-based Diabetic Eye Disease Screening System Product and Services
Table 77. Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Airdoc Recent Developments/Updates
Table 79. Airdoc Competitive Strengths & Weaknesses
Table 80. Zhiyuan Huitu Basic Information, Manufacturing Base and Competitors
Table 81. Zhiyuan Huitu Major Business
Table 82. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product and Services
Table 83. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Zhiyuan Huitu Recent Developments/Updates
Table 85. Zhiyuan Huitu Competitive Strengths & Weaknesses
Table 86. IDx, LLC Basic Information, Manufacturing Base and Competitors
Table 87. IDx, LLC Major Business
Table 88. IDx, LLC AI-based Diabetic Eye Disease Screening System Product and Services
Table 89. IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. IDx, LLC Recent Developments/Updates
Table 91. IDx, LLC Competitive Strengths & Weaknesses
Table 92. Zhenhealth Basic Information, Manufacturing Base and Competitors
Table 93. Zhenhealth Major Business
Table 94. Zhenhealth AI-based Diabetic Eye Disease Screening System Product and Services
Table 95. Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Zhenhealth Recent Developments/Updates
Table 97. Zhenhealth Competitive Strengths & Weaknesses
Table 98. Global Key Players of AI-based Diabetic Eye Disease Screening System Upstream (Raw Materials)
Table 99. Global AI-based Diabetic Eye Disease Screening System Typical Customers
LIST OF FIGURES
Figure 1. AI-based Diabetic Eye Disease Screening System Picture
Figure 2. World AI-based Diabetic Eye Disease Screening System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI-based Diabetic Eye Disease Screening System Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 13. AI-based Diabetic Eye Disease Screening System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI-based Diabetic Eye Disease Screening System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI-based Diabetic Eye Disease Screening System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-based Diabetic Eye Disease Screening System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-based Diabetic Eye Disease Screening System Markets in 2025
Figure 27. United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI-based Diabetic Eye Disease Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type in 2025
Figure 31. On-premise
Figure 32. Cloud-based
Figure 33. Hybrid Mode
Figure 34. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2032)
Figure 35. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model, (USD Million), 2021 & 2025 & 2032
Figure 36. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model in 2025
Figure 37. Software Licensing
Figure 38. SaaS Subscription
Figure 39. Per-Screening Fee
Figure 40. Integrated AI + Hardware Sales
Figure 41. Others
Figure 42. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2032)
Figure 43. World AI-based Diabetic Eye Disease Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application in 2025
Figure 45. General Hospitals
Figure 46. Ophthalmology Hospitals
Figure 47. Diabetes Specialty Hospitals
Figure 48. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2032)
Figure 49. AI-based Diabetic Eye Disease Screening System Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. AI-based Diabetic Eye Disease Screening System Picture
Figure 2. World AI-based Diabetic Eye Disease Screening System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI-based Diabetic Eye Disease Screening System Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI-based Diabetic Eye Disease Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI-based Diabetic Eye Disease Screening System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI-based Diabetic Eye Disease Screening System Revenue (2021-2032) & (USD Million)
Figure 13. AI-based Diabetic Eye Disease Screening System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI-based Diabetic Eye Disease Screening System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI-based Diabetic Eye Disease Screening System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI-based Diabetic Eye Disease Screening System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-based Diabetic Eye Disease Screening System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-based Diabetic Eye Disease Screening System Markets in 2025
Figure 27. United States VS China: AI-based Diabetic Eye Disease Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI-based Diabetic Eye Disease Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI-based Diabetic Eye Disease Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type in 2025
Figure 31. On-premise
Figure 32. Cloud-based
Figure 33. Hybrid Mode
Figure 34. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Type (2021-2032)
Figure 35. World AI-based Diabetic Eye Disease Screening System Market Size by Business Model, (USD Million), 2021 & 2025 & 2032
Figure 36. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model in 2025
Figure 37. Software Licensing
Figure 38. SaaS Subscription
Figure 39. Per-Screening Fee
Figure 40. Integrated AI + Hardware Sales
Figure 41. Others
Figure 42. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Business Model (2021-2032)
Figure 43. World AI-based Diabetic Eye Disease Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application in 2025
Figure 45. General Hospitals
Figure 46. Ophthalmology Hospitals
Figure 47. Diabetes Specialty Hospitals
Figure 48. World AI-based Diabetic Eye Disease Screening System Market Size Market Share by Application (2021-2032)
Figure 49. AI-based Diabetic Eye Disease Screening System Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
